Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director
Inv. presentation

Molecular Templates, Inc. (MTEM) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/18/2021 GN Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results
02/17/2021 GN Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
02/11/2021 GN Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
12/21/2020 GN Molecular Templates, Inc. Provides Update on MT-5111 Phase 1 Study
11/30/2020 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM
11/25/2020 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM
11/21/2020 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM
11/16/2020 GN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molecular Templates, Inc. - MTEM
11/16/2020 GN Molecular Templates to Participate in Upcoming Virtual Investor Conferences
11/05/2020 GN Molecular Templates, Inc. Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
09/03/2020 GN Molecular Templates to Participate in September Virtual Investor Conferences
08/06/2020 GN Molecular Templates, Inc. Reports Second Quarter 2020 Financial Results
07/20/2020 GN Molecular Templates, Inc. Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility
06/22/2020 GN Molecular Templates' Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2020 Highlight Evolution of ETB Platform
05/22/2020 GN Molecular Templates, Inc. Announces $45 Million Debt Financing From K2 HealthVentures
05/15/2020 GN New Data on Molecular Templates' Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II
05/13/2020 GN Molecular Templates to Participate in Two May Virtual Investor Conferences
05/11/2020 GN Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
05/07/2020 GN Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format
03/12/2020 GN Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
02/19/2020 GN Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma
12/19/2019 GN Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
12/09/2019 GN Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting
11/21/2019 GN Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering
11/20/2019 GN Molecular Templates, Inc. Announces Proposed Public Equity Offering
11/18/2019 GN Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
11/12/2019 GN Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
11/07/2019 GN Molecular Templates Hosting Analyst & Investor Meeting
09/23/2019 GN Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
08/12/2019 GN Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results
06/17/2019 GN Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38
05/13/2019 GN Molecular Templates, Inc. Reports First Quarter 2019 Financial Results
04/25/2019 GN The Judge Group Named a Winner of the Delaware Valley 2019 Top Workplaces Award by Philadelphia Media Network
04/10/2019 GN Factors of Influence in 2019, Key Indicators and Opportunity within Cousins Properties, Versum Materials, Meritor, Ardelyx, Molecular Templates, and Talend S.A — New Research Emphasizes Economic Growth
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy